Stroke prevention in atrial fibrillation with chronic kidney disease: a delicate balance of efficacy and safety considerations

被引：0
|
作者：
Barnes, Geoffrey D. [1 ]
Nunes, Julie A. Wright [2 ]
机构：
[1] Univ Michigan, Frankel Cardiovasc Ctr, Dept Internal Med, Div Cardiovasc Med, 2800 Plymouth Rd B14 G214, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2024年 / 8卷 / 02期
关键词：
HEMODIALYSIS; APIXABAN;
D O I：
10.1016/j.rpth.2024.102370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy and safety of edoxaban in patients with atrial fibrillation (AF) and severe chronic kidney disease (CKD)
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N25 - N26
  • [22] Comparing the Efficacy and Safety of Apixaban and Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease
    Asgar, Juzer Ali
    Benchakroun, Amal
    Sass, Nicholas
    Hassani, Samar
    Efuet-Ateh, Leonard
    Koss, Harrison
    Jones, Can
    Ostos, Catherine
    Alvarado, Francisco
    Chait, Robert
    BLOOD, 2024, 144 : 5583 - 5584
  • [23] Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation
    Eikelboom, J. W.
    Quinlan, D. J.
    Connolly, S. J.
    Hart, R. G.
    Yusuf, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) : 966 - 968
  • [24] Secondary Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation and Advanced Chronic Kidney Disease
    Ren, Yanzhao
    Miao, Menglong
    Tan, Ruopeng
    Xu, Guiwen
    Liu, Yang
    Yin, Xiaomeng
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025,
  • [25] Renal Function Considerations for Stroke Prevention in Atrial Fibrillation
    Fanikos, John
    Burnett, Allison E.
    Mahan, Charles E.
    Dobesh, Paul P.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (09): : 1015 - 1023
  • [26] Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation
    Price, Matthew J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 542 - 549
  • [27] Oral anticoagulation in patients with atrial fibrillation and advanced chronic kidney disease: additional kidney benefits beyond stroke prevention
    Kreutz, Reinhold
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (11):
  • [28] Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
    Szummer, K.
    Trevisan, M.
    Barany, P.
    Xu, H.
    Evans, M.
    Carrero, J. J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 974 - 974
  • [29] Safety and efficacy of rivaroxaban compared to warfarin in patients with atrial fibrillation and advanced stages of chronic kidney disease
    Chashkina, M.
    Andreev, D. A.
    Kozlovskaya, N. L.
    Salpagarova, Z. K.
    Bykova, A. A.
    Suvorov, A. Y.
    Baturina, O. A.
    Osipova, A., I
    Syrkin, A. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3323 - 3323
  • [30] Safety and efficacy of low-dose rivaroxaban in Asian patients with atrial fibrillation and chronic kidney disease
    Liu, L.
    Tseng, Y. J.
    Lin, P. L.
    Chiou, W. R.
    Lee, Y. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3375 - 3375
12345